Aileron Therapeutics Closes Direct Offering of Shares, Warrants
Aileron Therapeutics (ALRN) said late Friday it closed an underwritten registered direct offering of about 4.3 million shares and warrants to buy the same number of shares. Each share and warrant were
MT NewswiresMay 3 16:33 ET
Express News | Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million
ReutersMay 3 16:05 ET
Aileron Therapeutics(ALRN.US) 10% Shareholder Sells US$139.1K in Common Stock
$Aileron Therapeutics(ALRN.US)$ 10% Shareholder UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO sold 31,151 shares of common stock on Apr 29, 30, May 1, 2024 at an average price of $4.465 for a
moomoo NewsMay 1 19:55 ET
Express News | Aileron Therapeutics Inc: Entered Into an Underwriting Agreement With Titan Partners Group LLC, as Underwriter
ReutersMay 1 17:27 ET
Express News | Aileron Therapeutics Shares Are Trading Lower After the Company Announced the Pricing of an Underwritten Registered Direct Offering of 4,273,505 Shares and Accompanying Warrants at a Combined Offering Price of $4.68
BenzingaMay 1 11:57 ET
Express News | Aileron Therapeutics Prices 4,273,505 Offering Of Shares And Accompanying Warrants At Combined Offering Price Of $4.68
BenzingaMay 1 08:56 ET
Express News | Aileron Therapeutics Announces Pricing of Underwritten Registered Direct Offering Priced at-the-Market Under Nasdaq Rules of up to Approximately $40 Million
ReutersMay 1 08:45 ET
Express News | Aileron Therapeutics Inc: Results Show Lti-03 to Be Generally Well-Tolerated With No Serious Adverse Events (Saes) Reported
ReutersMay 1 08:32 ET
Express News | Aileron Therapeutics Inc: Positive Trend Was Observed in Seven of Eight Ipf Biomarkers Evaluated
ReutersMay 1 08:30 ET
Express News | Aileron Therapeutics Inc: Low-Dose Lti-03 Was Well-Tolerated, With No Safety Signal Observed
ReutersMay 1 08:30 ET
Express News | Aileron Therapeutics Inc: Data From Cohort 2 Evaluating High-Dose Lti-03 (5 Mg Bid) Is Expected in Q3 of 2024
ReutersMay 1 08:30 ET
Express News | Aileron Therapeutics Announces Positive Data From Cohort 1 of the Phase 1B Clinical Trial of Lti-03 in Idiopathic Pulmonary Fibrosis (Ipf)
ReutersMay 1 08:30 ET
Form 144 | Aileron Therapeutics(ALRN.US) 10% Stockholder Proposes to Sell 3.62 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 29, $Aileron Therapeutics(ALRN.US)$ 10% Stockholder UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO intends to sell 723.98K shares of its common stock on Apr 29, with
moomoo NewsApr 29 17:07 ET
CGC, GENE and HOLO Among Mid-day Movers
Seeking AlphaApr 18 12:42 ET
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersBio-Path Hldgs (NASDAQ:BPTH) stock moved upwards by 67.1% to $5.42 during Thursday's regular session. The market value of their outstanding shares is at $4.0 million. Aileron Therapeutics (NASD
BenzingaApr 18 12:31 ET
Express News | Aileron Therapeutics Shares Are Trading Higher After Ladenburg Thalmann Maintained a Buy Rating on the Stock and Raised Its Price Target From $9 to $19. Also, the Company Filed U.S. Patent Application Number 20240124518 Titled "Methods For Preparing Purif
Moomoo 24/7Apr 18 12:18 ET
Express News | Aileron Therapeutics Filed U.S. Patent Application #20240124518: Methods For Preparing Purified Polypeptide Compositions
Moomoo 24/7Apr 18 11:50 ET
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Las Vegas Sands Corp. (NYSE:LVS) fell sharply during Thursday's session despite better-than-expected first-quarter results.The company reported quarterly adjusted earnings of 75 cents per sh
BenzingaApr 18 11:32 ET
Veru, EyePoint Pharmaceuticals, SINTX Technologies Among Healthcare Movers
Seeking AlphaApr 18 10:00 ET
Aileron Therapeutics Is Maintained at Buy by Ladenburg Thalmann
Aileron Therapeutics Is Maintained at Buy by Ladenburg Thalmann
Dow JonesApr 18 08:46 ET
No Data
No Data